+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lyme Disease Diagnostics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027

  • Report

  • 100 Pages
  • March 2022
  • Region: Global
  • Infinium Global Research
  • ID: 5572514
The report on the global lyme disease diagnostics market provides qualitative and quantitative analysis for the period from 2019 to 2027. The report predicts the global lyme disease diagnostics market to grow with a healthy CAGR over the forecast period from 2021-2027. The study on lyme disease diagnostics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.

The report on lyme disease diagnostics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global lyme disease diagnostics market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global lyme disease diagnostics market over the period of 2019 to 2027. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings


1) Drivers
  • Rising prevalence of lyme disease
  • Increasing focus of governments towards improvement of healthcare facilities
2) Restraints
  • Inefficiency in lyme disease testing
3) Opportunities
  • Players of the lyme disease diagnosis market are focusing on research and development

Research Methodology


A) Primary Research


The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents who are approached include

1. Key Opinion Leaders associated with the Publisher
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include:

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research


Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At the publisher, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include:

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segments Covered


The global lyme disease diagnostics market is segmented on the basis of emerging diagnostic technology, and end user.

The Global Lyme Disease Diagnostics Market by Emerging Diagnostic Technology

  • Serological Test
  • Urine Antigen Tests
  • Immunofluorescent Staining
  • Nucleic Acid Test
  • Others

The Global Lyme Disease Diagnostics Market by End User

  • Hospitals
  • Public and Private Laboratories

Company Profiles


The companies covered in the report include:

  • Abbott Laboratories
  • T2 Biosystems
  • Bio-Rad Laboratories
  • Alere Inc.
  • Roche Diagnostics International Ltd.
  • Graphene Frontiers
  • Covance Inc.

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the lyme disease diagnostics market.
2. Complete coverage of all the segments in the lyme disease diagnostics market to analyze the trends, developments in the global market and forecast of market size up to 2027.
3. Comprehensive analysis of the companies operating in the global lyme disease diagnostics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Lyme Disease Diagnostics Market Highlights
2.2. Lyme Disease Diagnostics Market Projection
2.3. Lyme Disease Diagnostics Market Regional Highlights
3. Global Lyme Disease Diagnostics Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Lyme Disease Diagnostics Market
3.4. Porter's Five Forces Analysis
3.5. IGR-Growth Matrix Analysis
3.5.1. IGR-Growth Matrix Analysis by Emerging Diagnostic Technology
3.5.2. IGR-Growth Matrix Analysis by End User
3.5.3. IGR-Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Lyme Disease Diagnostics Market
4. Lyme Disease Diagnostics Market Macro Indicator Analysis
5. Global Lyme Disease Diagnostics Market by Emerging Diagnostic Technology
5.1. Serological Test
5.2. Urine Antigen Tests
5.3. Immunofluorescent Staining
5.4. Nucleic Acid Test
5.5. Others
6. Global Lyme Disease Diagnostics Market by End User
6.1. Hospitals
6.2. Public and Private Laboratories
7. Global Lyme Disease Diagnostics Market by Region 2021-2027
7.1. North America
7.1.1. North America Lyme Disease Diagnostics Market by Emerging Diagnostic Technology
7.1.2. North America Lyme Disease Diagnostics Market by End User
7.1.3. North America Lyme Disease Diagnostics Market by Country
7.2. Europe
7.2.1. Europe Lyme Disease Diagnostics Market by Emerging Diagnostic Technology
7.2.2. Europe Lyme Disease Diagnostics Market by End User
7.2.3. Europe Lyme Disease Diagnostics Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Lyme Disease Diagnostics Market by Emerging Diagnostic Technology
7.3.2. Asia-Pacific Lyme Disease Diagnostics Market by End User
7.3.3. Asia-Pacific Lyme Disease Diagnostics Market by Country
7.4. RoW
7.4.1. RoW Lyme Disease Diagnostics Market by Emerging Diagnostic Technology
7.4.2. RoW Lyme Disease Diagnostics Market by End User
7.4.3. RoW Lyme Disease Diagnostics Market by Sub-region
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Lyme Disease Diagnostics Market
8.2. Companies Profiled
8.2.1. Abbott Laboratories
8.2.2. T2 Biosystems
8.2.3. Bio-Rad Laboratories
8.2.4. Alere Inc.
8.2.5. Roche Diagnostics International Ltd.
8.2.6. Graphene Frontiers
8.2.7. Covance Inc.

Executive Summary

The report on lyme disease diagnostics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global lyme disease diagnostics market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.

Companies Mentioned

  • Abbott Laboratories
  • T2 Biosystems
  • Bio-Rad Laboratories
  • Alere Inc.
  • Roche Diagnostics International Ltd.
  • Graphene Frontiers
  • Covance Inc.